• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Preparation and characterization of polymorphs for an LTD4 antagonist, RG 12525.

作者信息

Carlton R A, Difeo T J, Powner T H, Santos I, Thompson M D

机构信息

Rhöne-Poulenc Rorer, Collegeville, PA 19426, USA.

出版信息

J Pharm Sci. 1996 May;85(5):461-7. doi: 10.1021/js950265p.

DOI:10.1021/js950265p
PMID:8742935
Abstract

This report describes the preparation and characterization of two polymorphic forms of RG 12525, a leukotriene D4 (LTD4) antagonist. Polymorph I is prepared by recrystallization from methanol or titration of the sodium salt of RG 12525 with citric acid. Polymorph II is prepared by recrystallization from methanol or titration of the ammonium salt of RG 12525 with citric acid. The polymorphic system is enantiotropic, with pure form I melting at 154 degrees C, 3 deg less than the melting temperature of form II. Form I is thermodynamically more stable than form II at room temperature. These polymorphic forms are differentiated using microscopy, differential scanning calorimetry (DSC), infrared spectroscopy (IR), and powder X-ray diffraction (XRD) analysis. Solubility properties from 31 to 72 degrees C were determined to be similar for both forms. The calculated solubilities at 25 degrees C are 7.6 and 9.8 microM for forms I and II, respectively. The free energy change from form II to form I at 25 degrees C is -0.15 kcal/mol. Thermodynamic properties of the system are summarized using a schematic free energy diagram.

摘要

相似文献

1
Preparation and characterization of polymorphs for an LTD4 antagonist, RG 12525.
J Pharm Sci. 1996 May;85(5):461-7. doi: 10.1021/js950265p.
2
Solid state characterization of dehydroepiandrosterone.脱氢表雄酮的固态表征
J Pharm Sci. 1995 Oct;84(10):1169-79. doi: 10.1002/jps.2600841007.
3
Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.采用X射线粉末衍射、差示扫描量热法和衰减全反射傅里叶变换红外光谱法对原料药和片剂制剂中甲磺酸伊马替尼的两种多晶型进行定量测定。
J Pharm Biomed Anal. 2015 Oct 10;114:330-40. doi: 10.1016/j.jpba.2015.06.011. Epub 2015 Jun 12.
4
Solid state characterization of E2101, a novel antispastic drug.新型抗痉挛药物E2101的固态表征
J Pharm Sci. 2002 Oct;91(10):2193-202. doi: 10.1002/jps.10211.
5
Investigation of moricizine hydrochloride polymorphs.盐酸莫雷西嗪多晶型物的研究
J Pharm Sci. 1994 Oct;83(10):1404-6. doi: 10.1002/jps.2600831008.
6
The polymorph landscape of dabigatran etexilate mesylate: Taking the challenge to bring a metastable polymorph to market.甲磺酸达比加群酯的多晶型景观:接受挑战将亚稳定多晶型推向市场。
Eur J Pharm Sci. 2023 Jul 1;186:106447. doi: 10.1016/j.ejps.2023.106447. Epub 2023 Apr 11.
7
Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.制备无定形呋塞米钠盐可提高溶解度和溶出速率,并导致大鼠口服给药后的 Tmax 更快。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):942-51. doi: 10.1016/j.ejpb.2013.09.002. Epub 2013 Sep 27.
8
Polymorphism of roxifiban.罗昔非班的多态性
J Pharm Sci. 2002 Dec;91(12):2599-604. doi: 10.1002/jps.10078.
9
Polymorphism of 1,2-dihydro-6-neopentyl-2-oxonicotinic acid: characterization, interconversion, and quantitation.1,2-二氢-6-新戊基-2-氧代烟酸的多态性:表征、相互转化及定量分析
Pharm Res. 1987 Oct;4(5):429-32. doi: 10.1023/a:1016498731952.
10
Solubility and crystal nucleation in organic solvents of two polymorphs of curcumin.姜黄素两种多晶型物在有机溶剂中的溶解度和晶体成核
J Pharm Sci. 2015 Jul;104(7):2183-9. doi: 10.1002/jps.24463. Epub 2015 May 6.